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CENTRAL VENOUS OXYGEN SATURATION MONITORING 
 
ABSTRACT  
It has been established that mixed venous oxygen saturation (SvO2) reflects the 
balance between systemic oxygen deliver y and consumption. Literature indicates 
that it is a valuable clinical indicator and has good prognostic value early in patient 
course. This article aims to establish the usefulness of SvO2 as a clinical indicator. A 
secondary aim was to determine whether central venous oxygen saturation (ScvO2) 
and SvO2 are interchangeable. Of particular relevance to cardiac nurses is the link 
between decreased SvO2 and cardiac failure in patients with myocardial infarction, 
and with decline in myocardial function, clinical shock and arrhythmias. While 
absolute values ScvO2 and SvO2 are not interchangeable, ScvO2 and SvO2are 
equivalent in terms of clinical course. Additionally, ScvO2 monitoring is a safer and 
less costly alternative to SvO2 monitoring. It can be concluded that continuous 
ScvO2 monitoring should potentially be undertaken in patients at risk of 
haemodynamic instability. 
 
KEY WORDS 
Oxygen saturation; monitoring; blood gases. 
 
KEY POINTS 
• Venous oxygen saturation has been advocated as an indirect index of tissue 
oxygenation. 
• It is generally accepted that venous oxygen saturation reveals a discrepancy 
between oxygen supply and oxygen demand thus indicating global tissue 
hypoxia. 
• Mixed venous oxygen saturation monitoring can detect tissue ischaemia at an 
early stage, and thus is a valuable indicator of clinical course. 
• Central venous oxygen saturation and mixed venous oxygen saturation are 
interchangeable in the course of clinical decision making. 
• Continuous central venous oxygen saturation monitoring should be  
undertaken in patients at risk of haemodynamic instability and low cardiac 
output. 
 
Background 
Haemodynamic monitoring is an assessment cornerstone for all critically ill patients 
in the intensive care unit. It will identify haemodynamic instability, indicate its cause 
and monitor the patient’s response to therapy (Pinsky, 2007). Sustained tissue 
hypoxia is one of the principle factors in multi-organ failure, and thus recognition, 
treatment and prevention of tissue hypoxia is an essential component of care 
(Reinhart and Bloos, 2005; Marx and Reinhart, 2006; Bracht et al, 2007). Venous 
oximetry is used in this capacity and has been shown to identify global tissue 
hypoxia in patients with otherwise normal observations and vital signs (Ander et al, 
1998).  
 
Venous oximetry encompasses measurements of mixed venous oxygen saturations 
(SvO2) and central venous oxygen saturations (ScvO2) (Bracht et al, 2006; Marx 
and Reinhart, 2006). SvO2 refers to the haemoglobin saturation of blood drawn from 
the proximal pulmonary artery, and reflects the oxygen balance of the whole body 
(Reinhart and Bloos, 2005; Varpula et al, 2006). ScvO2 refers to the haemoglobin 
saturation of blood from the superior vena cava (Marx and Reinhart, 2006; Bracht et 
al, 2007). This measurement reflects the venous oxygen saturations of blood from 
the brain and upper body, but neglects venous blood from the lower body (Rivers et 
al, 2001a; Turnaoglu et al, 2001). It has been proposed that ScvO2 provides a mirror 
of SvO2 and consequently that the two measures are interchangeable. 
 
Applications of mixed venous oxygen saturations (SvO2) 
SvO2 has been proposed as an indicator of the balance between systemic oxygen 
delivery and consumption and thus can be used to assess the adequacy of tissue 
oxygenation (Pearse et al, 2005; Bracht et al, 2006; Marx and Reinhart, 2006; 
Ramakrishna et al, 2006). Blood contained in the pulmonary artery consists of mixed 
venous blood from organ systems and regions of the body. Thus, SvO2 reflects the 
average venous oxygen saturation of the whole body as measurements are obtained 
via the pulmonary artery (Turnaoglu et al, 2001). 
 
SvO2 can be measured intermittently by blood sampling and co-oximetry or 
continuously by a spectrophotometric catheter (Pearse et al, 2005). Low SvO2 
values indicate a mismatch between oxygen delivery and oxygen requirements and 
can occur when systemic oxygen delivery has been compromised or demands have 
exceeded supply (Rivers et al, 2001a; Marx and Reinhart, 2006). The normal range 
of SvO2 is 65-75% and reflects the balance between systemic oxygen delivery and 
consumption (Rivers et al, 2001a; Marx and Reinhart, 2006). 
 
Occult tissue hypoxia occurs when there is an imbalance of tissue oxygen demand 
and tissue oxygen delivery (Pinsky, 2007) The ability to detect occult tissue hypoxia 
early in the course of care while it is still potentially responsive to treatment is a huge 
benefit of SvO2 measurement (Kupeli and Satwicz, 1989; Rivers et al, 2001a; 
Pinsky, 2007). SvO2 is advocated as an early indicator of increased oxygen 
consumption and inadequate oxygen delivery when other vital signs are within a 
normal range (Kupeli and Satwicz, 1989; Reinhart and Bloos, 2005). 
 
As early as the 1960s, decreased SvO2was found to be indicative of imminent or 
current cardiac failure in patients with myocardial infarction (Goldman et al, 1968a). 
Similarly, SvO2 declines have been found to precede the decline of myocardial 
functioning, the onset of clinical shock, and arrhythmias, even when physiological 
signs were within normal limits (Rivers et al, 2001a; Ramakrishna et al, 2006). 
Absolute values differ among patient groups and study populations, but SvO2 levels 
less than 65-70% indicate increased tissue oxygen extraction and thus inadequate 
systemic oxygen delivery (Pinsky, 2007). Research has also found SvO2 to be 
superior to mean arterial pressure and heart rate in predicting declines in cardiac 
surgical patients (Rivers et al, 2001a). Furthermore, SvO2 has been found to carry 
prognostic significance as a predictor for death and has been shown to reduce 
morbidity and healthcare resource consumption in postoperative cardiac patients 
(Rivers et al, 2001a).  
 
SvO2 as a clinical indicator  
A number of observational and prospective clinical studies have demonstrated the 
prognostic significance of SvO2. These studies have encompassed a variety of 
patient groups including general surgical, cardiac surgical, myocardial infarction and 
cardiac disease, cardiogenic shock, and severe sepsis and septic shock. A small 
study found SvO2 correlated well with the duration of cardiac arrest (Van Riper et al, 
1988). SvO2 was found to correlate well with clinical course and be of prognostic 
value in patients in cardiogenic and septic shock and in postoperative cardiac 
surgery patients (Edwards, 1991; Svedjeholm et al, 1999). Polonen and Ruokonen 
(2000) also examined SvO2 in cardiac surgery patients. Findings indicated that 
patients treated with a goal of SvO2 above 70% had a shorter hospital stay and 
lower morbidity than patients provided with standard treatment (Polonen et al, 2000). 
Overwhelmingly, evidence from observational and prospective clinical studies 
indicates that SvO2 correlates well with clinical course and is a valuable clinical 
indicator. 
 
Potential problems measuring SvO2 
Measurement of SvO2 involves the placement of a pulmonary artery catheter. The 
controversy surrounding these catheters when they were introduced 30 years ago 
remains today (Harvey et al, 2005; Marx and Reinhart, 2006). Health risks 
associated with insertion of a pulmonary artery catheter and later complications 
include arrhythmias, catheter knotting, pulmonary artery perforation and infection 
(Bowdle, 2002; Reinhart and Bloos, 2005; Marx and Reinhart, 2006; Yazigi et al, 
2008). Observational studies suggest increased mortality levels are associated with 
pulmonary artery catheter usage (Connors et al, 1996). However, two large scale 
randomized control trials found no difference in hospital mortality between patients 
with a pulmonary artery catheter and those without (Sandham et al, 2003; Harvey 
et al, 2005). As a result of conflicting findings controversy surrounding the use of 
pulmonary artery catheters remains. Furthermore, increasing doubt exists regarding 
whether the advantages of pulmonary artery catheters outweigh the potential risks. 
Research indicates however, that ScvO2 mirrors SvO2. Thus ScvO2 may be 
considered as a safer alternative to SvO2 for monitoring tissue oxygenation (Table 
1). 
 
TAKE IN TABLE 1 HERE. 
 
Central venous oxygen saturations versus mixed oxygen saturations 
Monitoring ScvO2 has been suggested as a safer and more cost effective alternative 
to monitoring SvO2 (Ramakrishna et al, 2006; Yazigi et al, 2008). A central venous 
catheter is routinely inserted in patients admitted to the intensive care unit, thus all 
patients eligible for a central venous catheter may theoretically benefit from ScvO2 
monitoring (Reinhart and Bloos, 2005; Bracht et al, 2006; Marx and Reinhart, 2006). 
Variations in regional perfusion and oxygen consumption between different organ 
systems result in different venous oxygen saturation levels (Marx and Reinhart, 
2006; Yazigi et al, 2008). In healthy, functioning people ScvO2 is generally 2-5% 
lower than SvO2, as the brain extracts more oxygen than organ systems in the lower 
body (Kupeli and Satwicz, 1989; Reinhart et al, 2004; Marx and Reinhart, 2006). 
However, differences between the two values are not constant and may be affected 
by various conditions that induce haemodynamic instability, including general 
anaesthetic, head injury and redistribution of blood flow as occurs in shock (Reinhart 
and Bloos, 2005; Bracht et al, 2006). 
 
Effects of shock, sepsis and septic shock 
Shock involves a critical reduction in systemic oxygen delivery resulting in 
inadequate tissue perfusion. The body compensates by increasing systemic oxygen 
extraction to maintain perfusion, resulting in increased oxygen consumption in non-
vital organs thus altering the values of SvO2 and ScvO2 (Edwards, 1991). In 
critically ill patients ScvO2 is often higher than SvO2, suggesting pathologic ScvO2 
indicates even lower SvO2 (Reinhart and Bloos, 2005). Different organ systems 
extract different amounts of oxygen thus absolute values of ScvO2 and SvO2 are not 
interchangeable (Turnaoglu et al, 2001; Bracht et al, 2007). However, the literature 
overwhelmingly indicates that changes in ScvO2 correlate well with SvO2 and that 
the two are equivalent provided absolute values are not required (Scheinman et al, 
1969; Martin et al, 1992; Turnaoglu et al, 2001; Bracht et al, 2006; Marx and 
Reinhart, 2006; Varpula et al, 2006; Bracht et al, 2007). It has been found that 
although values are not exactly equivalent they are pathologically equivalent with low 
values of both ScvO2 and SvO2 associated with high morbidity and mortality (Rivers 
et al, 2001a). Additionally, positive changes in SvO2 due to therapeutic interventions 
are well reflected in ScvO2 with changes occurring in a parallel manner (Reinhart 
and Bloos, 2005; Marx and Reinhart, 2006).  
 
The general consensus in the literature is that trends in SvO2 are mirrored in ScvO2 
and thus are interchangeable so long as absolute values are not required (Dueck et 
al, 2005). As early as the 1960s, observational and prospective clinical studies 
examining whether ScvO2 and SvO2 are interchangeable have been conducted. 
Seminal studies performed in 1968 and 1969 found a correlation between changes 
in ScvO2 and SvO2 in critically ill cardiac patients with myocardial infarction, 
congestive heart failure and cardiogenic shock (Goldman et al, 1968a; Scheinman et 
al, 1969). Interest in this area continued, and was examined in a heterogeneous 
group of ICU patients. Lee et al (1972) found ScvO2 to be a good reflection of SvO2 
in patients not in shock, but found an unreliable correlation in septic shock patients. 
Similarly, Varpula and Karlsson (2006) found that ScvO2 and SvO2 only changed in 
the same direction approximately half of the time, and thus could not be considered 
equivalent. However, Martin et al (1992) and Turnaoglu et al (2001) found ScvO2 
paralleled changes in SvO2 in severe sepsis and septic shock patients. The 
discrepancy in findings may be attributed to the fact that the populations examined 
were admitted to the intensive care unit and thus were in advanced stages of sepsis 
and septic shock. In an advanced state of sepsis or septic shock, all organ systems 
extract greater amount of oxygen, resulting in hugely varied ScvO2 and SvO2 values 
(Varpula et al, 2006). 
 
Postoperative patients 
Surgical patients are a further subpopulation that has been focused on in 
determining the interchangeability of ScvO2 and SvO2. Two studies have examined 
postoperative cardiac surgical patients. Both found large variation between individual 
values of ScvO2 and SvO2 but showed a positive, significant correlation between 
changes in the values (Ramakrishna et al, 2006; Yazigi et al, 2008). Neurological 
surgical patients have also been examined in this context. Dueck et al (2005) found 
agreement between ScvO2 trends and SvO2 trends across changing hemodynamic 
conditions in these patients. In addition to specific clinical subpopulations, 
heterogeneous populations have also been examined. A number of studies have 
found differences in absolute values of ScvO2 and SvO2 but found agreement in 
trends in populations encompassing cardiac disease, cardiac surgery, severe sepsis 
and septic shock, trauma and mechanically ventilated patients (Berridge, 1992; 
Ladakis et al, 2001; Reinhart et al, 2004). Thus, evidence indicates that while ScvO2 
and SvO2 can not be substituted for one another in terms of absolute values, they 
are interchangeable with regardsto trends. An exception to this is the later treatment 
of severe sepsis and septic shock as controversy and uncertainty remains in this 
population. However, on the whole ScvO2 is equivalent to SvO2 in the course of 
clinical decisions provided absolute values are not required (Ramakrishna et al, 
2006). 
 
Application of central venous oxygen saturation measurement 
ScvO2 represents the reserve oxygen supply of the region from which the blood is 
drained, thus providing the rationale for evaluating ScvO2 as a goal (Varpula et al, 
2006; Bracht et al, 2007). ScvO2 provides a method of assessing the adequacy of 
tissue oxygenation and detecting occult tissue hypoxia early in the course of care 
(Rivers et al, 2001a; Pearse et al, 2005; Bracht et al, 2006; Marx and Reinhart, 2006; 
Ramakrishna et al, 2006). It has been demonstrated in canine experimental models 
that changes in ScvO2 closely reflect circulatory disturbances during periods of 
hypoxia, haemorrhage and resuscitation (Scalea et al, 1988; Reinhart et al, 1989). 
Goldman et al (1968b) conducted a seminal study in this area, finding a correlation 
between ScvO2 and clinical course in patients with myocardial infarction. Goldman 
et al (1968b) found patients not in heart failure had a mean ScvO2 of 70%, those in 
heart failure a mean of 56% and those in heart failure and clinical shock a mean of 
43%. However, despite these positive findings, interest in ScvO2 waned with 
research focusing on instead on SvO2. Rivers et al (2001b) conducted a large scale, 
prospective randomized study returning to ScvO2 as a haemodynamic parameter of 
interest. The study examined patients with severe sepsis or septic shock admitted to 
the emergency department. Patients in the treatment group underwent six hours of 
early goal-directed therapy with an aim to keep ScvO2 above 70%. It was found that 
mortality was reduced by 15% in patients who met ScvO2 goals as opposed to the 
control group who received standard treatment (Rivers et al, 2001b). These findings 
led to a renewed interest in ScvO2 as a clinical parameter, resulting in a number of 
large scale, observational studies. Three studies found ScvO2 values less than 70% 
preoperatively and intraoperatively predicted an increased risk of postoperative 
complications in high risk patients undergoing general surgery (Pearse et al, 2005; 
Bracht et al, 2006; Baulig et al, 2008). Additionally, Pearce et al (2005) found 
patients with ScvO2 values greater than 75% postoperatively did not develop 
postoperative complications. While a number of studies examining the role of ScvO2 
as a clinical indicator have been conducted, few interventional studies have been 
undertaken. However overwhelming evidence from these interventional studies and 
from observational and prospective studies indicates that ScvO2 has prognostic 
significance. 
 
Recommendations 
ScvO2 can be measured intermittently by drawing repeated blood samples from the 
central venous catheter and measuring the oxygen saturation via co-oximetry. This 
approach provides only intermittent information, increases health staff workload and 
results in unnecessary blood loss (Baulig et al, 2008). Alternatively, ScvO2 can be 
measured continuously via a spectrophotometric catheter. Advantages of continuous 
measurement include the provision of continuous data, decreased risk of infection as 
compared with intermittent sampling and conservation of time (Molnar et al, 2007; 
Muller et al, 2007; Baulig et al, 2008). Molnar et al (2007) found continuous ScvO2 
monitoring yielded results comparable with those obtained by intermittent blood 
sampling and co-oximetry. Consequently, the use of continuous monitoring of ScvO2 
is recommended as opposed to intermittent sampling. 
 Support for ScvO2 as a clinical indicator exists across a number of patient groups 
including general and cardiac surgical, myocardial infarction and cardiac disease, 
cardiogenic shock, and severe sepsis and septic shock. It is therefore suggested that 
ScvO2 be monitored continuously in patients from these groups who are at risk of 
haemodynamic instability and low cardiac output and that are eligible for a central 
venous catheter (Muller et al, 2007). Information regarding cutoff values for ScvO2 
varies between patient groups and studies, however ScvO2 levels below 70% have 
been found to be associated with increased morbidity and mortality (Polonen et al, 
2000; Rivers et al, 2001a; Pinsky, 2007). Thus treatment should be directed towards 
keeping ScvO2 levels above 70%. 
 
Conclusions 
The use of ScvO2 as a haemodynamic goal is becoming increasingly popular 
(Bracht et al, 2007). While SvO2 has been found to be a good clinical indicator of 
patient condition, evidence indicates ScvO2 and SvO2 to be interchangeable as long 
as absolute values are not required (Goldman et al, 1968; Rivers et al, 2001a; Dueck 
et al, 2005; Marx and Reinhart, 2006). Given these findings it would appear that 
ScvO2 is a valuable method of directing treatment in a range of patient groups. 
Furthermore, these findings suggest further research into the use of ScvO2 as a 
clinical indicator in other clinical subpopulations would be of merit. 
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Table 1: Summary of mixed versus central oxygen saturation monitoring. 
Measurement  Mixed venous oxygen 
saturations  
Central venous oxygen 
saturations 
Abbreviation: Svo2  Scvo2 
Blood drawn from: Proximal pulmonary artery  Superior vena cava 
Clinical picture: 
 
• Average venous oxygenation 
• Balance between systemic 
delivery and consumption 
• Venous oxygen saturations 
of blood from brain of whole 
body and upper body but not 
lower body 
Advantages: Systemic picture No pulmonary artery catheter 
required Patients in ICU 
routinely already have central 
venous catheter in place 
Disadvantages: Possible complications include 
arrhythmias, catheter knotting in 
patients, perforation of 
pulmonary artery, infection 
Unreliable correlation with 
systemic oxygenation in 
advanced sepsis/septic shock 
 
